- Home
- PHX vs VERU Comparison
PHX vs VERU Comparison
Compare PHX & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHX
- VERU
- Stock Information
- Founded
- PHX 1926
- VERU 1971
- Country
- PHX United States
- VERU United States
- Employees
- PHX N/A
- VERU N/A
- Industry
- PHX Oil & Gas Production
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- PHX Energy
- VERU Health Care
- Exchange
- PHX Nasdaq
- VERU Nasdaq
- Market Cap
- PHX 163.8M
- VERU 94.5M
- IPO Year
- PHX N/A
- VERU 1990
- Fundamental
- Price
- PHX N/A
- VERU $0.58
- Analyst Decision
- PHX Hold
- VERU Strong Buy
- Analyst Count
- PHX 1
- VERU 2
- Target Price
- PHX N/A
- VERU $4.00
- AVG Volume (30 Days)
- PHX 998.9K
- VERU 2.9M
- Earning Date
- PHX 08-06-2025
- VERU 08-07-2025
- Dividend Yield
- PHX 3.67%
- VERU N/A
- EPS Growth
- PHX 71.86
- VERU N/A
- EPS
- PHX 0.19
- VERU N/A
- Revenue
- PHX $36,057,255.00
- VERU $16,886,419.00
- Revenue This Year
- PHX $30.25
- VERU N/A
- Revenue Next Year
- PHX $4.76
- VERU N/A
- P/E Ratio
- PHX $23.02
- VERU N/A
- Revenue Growth
- PHX 16.49
- VERU 134.43
- 52 Week Low
- PHX $3.09
- VERU $0.45
- 52 Week High
- PHX $4.36
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- PHX 3.64
- VERU 47.42
- Support Level
- PHX $4.31
- VERU $0.56
- Resistance Level
- PHX $3.97
- VERU $0.73
- Average True Range (ATR)
- PHX 0.01
- VERU 0.05
- MACD
- PHX -0.47
- VERU -0.01
- Stochastic Oscillator
- PHX 0.00
- VERU 13.88
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.